Surfing MASH

A Message from Roger… “Hey, it's Roger Green, executive producer and host of the Surfing the MASH Tsunami podcast. We've been gone for a couple of months, but we'll be back over the next few weeks. We'll have an episode on Australia, one on the liver meeting, one for the end of the year wrap-up of an amazing year in Nashville, probably a couple of interviews with newsmakers. Over that time, we'll also be providing information on the new version of the podcast Surfing the MASH Tsunami 2.0 that we'll be bringing out to celebrate Season 6 in January 2025. So looking forward to being back with you. I'm back with Louise and Jörn and all our friends. And stay safe, surf on. We'll see you on the podcast, maybe in San Diego. See you there. Bye-bye now.” #SurfingMASH

𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗼𝗳 𝗧𝗵𝗲 𝗪𝗲𝗲𝗸: “Which approach will more significantly impact resmetirom treatment: using NITs to identify Advanced NASH patients or continuing therapy until disease progression?” ANSWER HERE: https://lnkd.in/eiq4AF4g #surfingmash #QuestionOfTheWeek #resmetirom #NITs

S5-E25 - Reviewing Expert Recommendations on the Use of Resmetirom Maru/Mary Rinella, corresponding author for the recent expert panel recommendations on resmetirom, joins the Surfers to discuss key points of the recommendations and the rationale behind them. https://lnkd.in/e8UbBQpg #resmetirom #expertrecommendations #ClinicalGastroenterologyandHepatology #NASHpodcast #SurfingNASH #FattyLiver Madrigal Pharmaceuticals

S5-24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication S5 E23 panelists Michael Betel and José Willemse join Roger Green to review the three answers audience members sent for Season 5 Episode 23's Question of the Week on Provider-Patient Communication. https://lnkd.in/e2D4TEXZ #AlliedHealth #Doctors #MASH #MASLDMetALD #Metabolic #Diseases #MotivationalInterviewing #PatientAdvocacy #PatientSupport #Programs #MotivatingFrontLineTreaters #PhysicianPatientDialogue #Provider #Education #PublicHealth #Stigma

S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI and other patient advocacy groups. https://lnkd.in/eBaBsMnP #EASLCongress hashtag#KeyTakeaways hashtag#GlobalLiver hashtag#NASHpodcast hashtag#SurfingNASH hashtag#FattyLiver 89bio, Akero Therapeutics, Boehringer Ingelheim, Global Liver Institute, Madrigal Pharmaceuticals, Novo Nordisk, Eli Lilly and Company

S5-E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways Global Liver Institute Vice President of Liver Programs Jeff McIntyre joins Roger Green to discuss what he considers key takeaways for GLI from EASL Congress 2024. https://lnkd.in/egPY8F4x #EASLCongress #KeyTakeaways #GlobalLiver #NASHpodcast #SurfingNASH #FattyLiver 89bio, Akero Therapeutics, Boehringer Ingelheim, Global Liver Institute, Madrigal Pharmaceuticals, Novo Nordisk, Eli Lilly and Company

S5-E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications PharmaNest Founder and CEO Mathieu Petitjean joins Roger Green to discuss key implications for his business from what he learned at EASL Congress 2024. https://lnkd.in/epgP-jz5 #EASLCongress #KeyImplications #PharmaNest #NASHpodcast #SurfingNASH #FattyLiver

S5-E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways PharmaNest Founder and CEO Mathieu Petitjean joins Roger Green to discuss key takeaways for his business from EASL Congress 2024. https://lnkd.in/eykXnRbX #EASLCongress #KeyTakeaways #PharmaNest #NASHpodcast #SurfingNASH #FattyLiver PharmaNest

August 5, 2024 - 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗢𝗳 𝗧𝗵𝗲 𝗪𝗲𝗲𝗸: “How have presentations or discussions from EASL Congress 2024 and the key lessons you learned reshape your thoughts about your work?” ANSWER: https://lnkd.in/eiq4AF4g #SurfingMASH #QoW #EASL2024

S5-E24 - 𝗔 𝗩𝗶𝗲𝘄 𝗼𝗳 𝗠𝗔𝗦𝗟𝗗: Looking Back at EASL Congress From Six Weeks Later PharmaNest Founder and CEO Mathieu Petitjean and Global LIver Institute Vice President of Liver Programs Jeff McIntyre join Roger Green for 1:1 interviews exploring their key takeaways and strategic shifts resulting from the EASL Congress 2024, followed by a review of answers to a previous Question of the Week. https://lnkd.in/eecwZQZQ #EASLCongress #MASLD #GlobalLiver #PharmaNest #NASHpodcast #SurfingNASH #FattyLiver 89bio, Akero Therapeutics, Boehringer Ingelheim, Global Liver Institute, Madrigal Pharmaceuticals, Novo Nordisk, Eli Lilly and Company, PharmaNest